arrow
L

Lukáš Dostálek

Arcispedale Sant Anna
H指数:16
被引数:1,186

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study

乳腺癌新辅助治疗后低体积淋巴结受累患者的腋窝清扫术:多中心AXSANA队列研究

2025-09-010
PRE
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)

新辅助化疗后乳腺癌症患者腋窝标记物丢失——来自前瞻性国际AXSANA(EUBREAST 3)队列研究(NCT04373655)的数据

2025-06-250
OA
Sentinel Node Biopsy Using Two Concurrent Labeling Techniques (Radioactive Tracer With/Without Blue Dye vs. Indocyanin Green-ICG) in Early-Stage Endometrial Cancer Patients (TESLA-1): A Prospective Observational Study CEEGOG EX-02

早期子宫内膜癌患者应用两种并行标记技术的哨兵淋巴结活检(放射性示踪剂联合/不联合蓝染料与吲哚菁绿-ICG)(TESLA-1):一项前瞻性观察研究 CEEGOG EX-02

CANCERS
IF4.4
2025-05-090
OA
Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study

早期宫颈癌单纯手术治疗中使用前哨淋巴结和淋巴结清扫术的生存率: 宫颈癌监测 (SCCAN) 合作研究的子分析

2024-11-010
OAAI
AXSANA - EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
2024-05-020
PRE
Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial

用于卵巢癌检测的血浆无细胞DNA甲基化分析: 病例对照研究和卵巢癌筛查试验的样本分析

2023-10-204
OAAI
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study

早期宫颈癌患者根治性子宫切除程度与生存率的相关性: 宫颈癌监测 (SCCAN) 合作研究的子分析

2023-10-017
PRE
The WID-EC test for the detection and risk prediction of endometrial cancer
2023-01-1710
OA
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy
2022-11-304
OA
TP53 field defects in uterine fluid are associated with ovarian cancer risk
2022-05-150
PRE
TP53 field defects in uterine fluid are associated with ovarian cancer risk
2022-05-150
PRE
AXSANA - EUBREAST 3 (axillary surgery after neoadjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)
2022-02-150
PRE
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer

用于宫颈癌患者定制监测策略的年度复发风险模型

2021-11-0129
OAAI
Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study
2021-01-0145
OAAI